Amazon puts Rs 350 crore in Amazon Pay India amid rising competition in fintech
E-commerce
giant Amazon has infused Rs 350 crore into its
fintech
arm,
Amazon Pay India
, as it seeks to bolster its presence in the country's competitive
digital payments
space dominated by
PhonePe
and
Google Pay
.
The move comes as rival Flipkart's fintech platform, Super.money, is reportedly in talks to raise $35–40 million in a new funding round, potentially bringing in external investors for the first time.
Regulatory filings with the Registrar of Companies (RoC) reveal that Amazon Pay India allotted 3.5 crore equity shares to its parent entity,
Amazon Corporate Holdings
Private Limited, through a rights issue. This latest capital infusion follows earlier investments of Rs 300 crore in November 2024 and Rs 600 crore in June 2024, according to an ET report.
Despite Amazon's continued investments, Amazon Pay's position in the UPI ecosystem has weakened. According to the National Payments Corporation of India (NPCI), the platform ranked eighth in
UPI transaction volume
as of March 2025 — down from sixth place a year earlier.
It now trails behind PhonePe, Google Pay, Paytm, Navi, Super.money, Axis Bank, and Cred.
NPCI data also shows that PhonePe and Google Pay together command roughly 85 per cent of the UPI transaction volume, while Amazon Pay holds a modest 0.6 per cent market share.
In February 2024, Amazon Pay secured a payment aggregator (PA) licence from the Reserve Bank of India, enabling it to expand its merchant payments operations — a potentially significant growth area given Amazon's strong e-commerce footprint.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Google Brain Co-Founder Andrew Ng, Recommends: Read These 5 Books And Turn Your Life Around
Blinkist: Andrew Ng's Reading List
Undo
This followed an earlier approval for a prepaid payments instrument (PPI) licence.
Amazon Pay currently offers a range of services including UPI transactions, bill payments, and insurance premium payments. It has formed strategic partnerships with platforms like BookMyShow, MakeMyTrip, RedBus, IRCTC, and Kuvera to branch into ticketing, travel, and wealth management.
For the fiscal year ending March 2024, Amazon Pay India reported a 9.22 per cent rise in operating revenue to Rs 2,286 crore, up from Rs 2,093 crore in FY23.
The company also managed to narrow its losses by 39 per cent, bringing them down to Rs 911 crore from Rs 1,499 crore.
Meanwhile, the Payments Council of India (PCI) has urged the Prime Minister's Office to reintroduce the merchant discount rate (MDR) for UPI and RuPay debit card transactions, at least for large merchants. The proposal aims to address concerns around the long-term sustainability of digital payment providers.
Amazon Pay India CEO Vikas Bansal had previously told ET that reintroducing MDR is essential to ensure smaller players in the UPI ecosystem are fairly compensated for their services.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
39 minutes ago
- News18
Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP
Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
India.com
41 minutes ago
- India.com
Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…
Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.
Hindustan Times
43 minutes ago
- Hindustan Times
Watch with Kannada numerals and Karnataka's iconic crest goes viral: 'Decolonize your mind'
BJP MP Tejasvi Surya criticizes Karnataka's Rs 18,000 crore tunnel road project, calling it unscientific and financially unsound. He questions the project's feasibility, high toll costs, and potential public fund drain, challenging the government's transportation strategy.
